The VeraCept Intrauterine Contraceptive is currently in a clinical study in the United States. It is limited by United States Federal Law to Investigational Use.
VeraCept is a hormone-free, low-dose copper releasing intrauterine device intended to prevent pregnancy. VeraCept is undergoing Phase 2 Clinical Trials in the United States and is preparing for CE Mark Application in the European Union.
The VeraCept Difference
Properties of VeraCept currently being investigated in the clinical study include:
- Lower copper dosage
- Smaller insertion profile
- Pre-loaded Introducer
- Pre-trimmed retrieval thread
- Flexible shape memory frame
Learn More About VeraCept
CAUTION: New Drug- Limited by Federal Law to Investigational Use.